Loading...
Loading...
shares declined 13.35 percent to $7.27 in pre-market trading after the company reported results from Phase 2 trial of MDX for Fragile X syndrome. The company said study did not meet primary endpoint of change on ADHD RS-IV inattentive subscale.
FireEye Inc FEYE fell 3.36 percent to $51.05 in pre-market trading after gaining 0.76 percent on Tuesday.
BIND Therapeutics Inc BIND shares fell 3.31 percent to $5.85 in pre-market trading after rising 3.24 percent on Tuesday.
Fortinet Inc FTNT shares tumbled 3.29 percent to $41.79 in pre-market trading. Baird downgraded Fortinet from Neutral to Underperform.
Compugen Ltd. (USA) CGEN shares dropped 2.38 percent to $7.37 in pre-market. Compugen shares have declined 19.51 percent over the past 52 weeks, while the S&P 500 index has gained 8.40 percent in the same period.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in